clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
Molecular Dx
U.K. Study Shows Most Cancer Patients Would Benefit from Pharmacogenetic Testing
News & Features
HTAN Members Deliver Wealth of Tumor Biology Insights
News & Features
How p53 Loss Drives Cancer Risk in Ulcerative Colitis
News & Features
Mechanisms Behind Myocarditis in Cancer Patients Treated with Immune Checkpoint Inhibitors…
News & Features
Case Study Suggests Some Men with Advanced Prostate Cancer Could Benefit…
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Formation Bio Nets $372M to Build Pipeline and Expand AI Platform
Sanofi
Informatics
Formation Bio Nets $372M to Build Pipeline and Expand AI Platform
July 2, 2024
0
News & Features
Merck Inks $1B Synthetic Biology Deal with Pearl
March 13, 2024
0
News & Features
Sanofi Acquires Inhibrx AAT Deficiency Drug Candidate For Up to $2.2B
January 23, 2024
0
News & Features
Sanofi and Teva Ink Deal Worth Potentially $1.5B for Anti-TL1A IBD Candidate
October 5, 2023
0
News & Features
Sanofi Inks Potential $1.2B+ Deal with Recludix for Immunology and Inflammatory Candidates
July 21, 2023
0
News & Features
Amgen Acquires Rare Disease Company Horizon Tx for Almost $28 Billion
December 12, 2022
0
News & Features
Protein Enhancement Therapeutics Company Entact Bio Raises $81M in Series A Round
December 6, 2022
0
News & Features
Sanofi, BioMed X Enter AI-Based Drug Development Collaboration
October 24, 2022
0
News & Features
Protalix and Chiesi’s Treatment for Fabry Disease Achieves Phase III Goals
March 18, 2022
0
News & Features
Exscientia Scores Deal With Sanofi To Develop Immuno-Oncology Drugs With AI
January 10, 2022
0
1
2
3
Page 1 of 3
Related Content
New Research Highlights How DNA Circles Drive Cancer Growth and Drug Resistance
Genes Linking Rheumatoid Arthritis and Osteoporosis Uncovered
Personalized Medicine: Past, Present, and Future
International Working Group Publishes Revised Diagnostic Criteria for Alzheimer's Disease
Inside Precision Medicine